Prader-Willi Syndrome

Beloranib to Be Tested in Prader-Willi Syndrome

Beloranib to Be Tested in Prader-Willi Syndrome

Beloranib for treatment of Prader-Willi syndrome enters phase 3 trial.

Sign Up for Free e-Newsletters



CME Focus